Activation of the c-Jun transcription factor following neurodegeneration in vivo

Neuroscience Letters

Volumn 361, Issue 1-3, 2004, Pages 36-39

  Schenkel, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

c Jun; Neurodegeneration; Transcription factor

Indexed keywords

PROTEIN C JUN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL POPULATION; CONTROLLED STUDY; DATA ANALYSIS; GENE TARGETING; IN VIVO STUDY; MEDIAL FOREBRAIN BUNDLE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE DEGENERATION; NERVE FIBER TRANSECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REPERFUSION; STROKE; SUBSTANTIA NIGRA; UPREGULATION;

ANIMALS; AXOTOMY; BRAIN ISCHEMIA; CELL DEATH; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; PROTO-ONCOGENE PROTEINS C-JUN; RETROGRADE DEGENERATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 2342634488     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.011     Document Type: Article

References (33)

1. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157
2. Behrens A., Sibilia M., Wagner E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21:1999;326-329
3. Beer J., Mielke K., Zipp M., Zimmermann M., Herdegen T. Expression of c-jun, junB, c-fos, fra-1 and fra-2mRNA in the rat brain following seizure activity and axotomy. Brain Res. 794:1998;255-266
4. Bossy-Wetzel E., Bakiri L., Yaniv M. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16:(7):1997;1695-1709
5. Deng T., Karin M. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7:1993;479-490
6. Ham J., Babij C., Whitfield J., Pfarr C.M., Lallemand D., Yaniv M., Rubin L.L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939
7. Herdegen T., Kovary K., Buhl A., Bravo R., Zimmermann M., Gass P. Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain. J. Comp. Neurol. 354:1995;39-56
8. Herdegen T., Skene P., Bähr M. The c-Jun protein-transcriptional mediator of neuronal survival, regeneration and death. Trends Neurosci. 20:1997;227-231
9. Herdegen T., Claret F.X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., Karin M. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci. 18:(14):1998;5124-5135
10. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336
11. Johnson R.S., van Lingen B., Papaioannou V.E., Spiegelman B.M. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7:1993;1309-1317
12. Kallunki T., Deng T., Hibi M., Karin M. c-jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 87:1996;929-939
13. Kang C.D., Jang J.H., Kim K.W., Lee H.J., Jeong C.S., Kim C.M., Kim S.H., Chung B.S. Activation of c-jun N-terminal kinase/stress-activated protein kinase and the decreased ratio of Bcl-2 to Bax are associated with the auto-oxidized dopamine-induced apoptosis in PC12 cells. Neurosci. Lett. 256:1998;37-40
14. Kim Y.H., Kim S.S. Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929 cells. Cytokine. 11:1999;274-281
15. Lee L., Irani K., Finkel T. Bcl-2 regulates nonapoptotic signal transduction: inhibition of c-Jun N-terminal kinase (JNK) activation by IL-1 beta and hydrogen peroxide. Mol. Genet. Metab. 64:1998;19-24
16. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., Debatin K.M. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19:1999;3809-3817
17. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J., Krammer P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8:(7):2001;679-686
18. Martinou J.C., Dubois-Dauphin M., Staple J.K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:(4):1994;1017-1030
19. Passegue E., Jochum W., Schorpp-Kistner M., Mohle-Steinlein U., Wagner E.F. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 104:2001;21-32
20. Passegue E., Jochum W., Behrens A., Ricci R., Wagner E.F. JunB can substitute for Jun in mouse development and cell proliferation. Nat. Genet. 30:(2):2002;158-166
21. Schorpp-Kistner M., Wang Z.Q., Angel P., Wagner E.F. JunB is essential for mammalian placentation. EMBO J. 18:(4):1999;934-948
22. Simi A., Ingelman-Sundberg M., Tindberg N. Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase. J. Cereb. Blood Flow Metab. 20:(7):2000;1077-1088
23. Sommer C., Gass P., Kiessling M. Selective c-Jun expression in CA1 neurons of the gerbil hippocampus during and after acquisition of an ischemia-tolerant state. Brain Pathol. 5:1995;135-144
24. Spanaus K.S., Schlapbach R., Fontana A. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur. J. Immunol. 28:(12):1998;4398-4408
25. Venero J.L., Revuelta M., Cano J., Machado A.J. Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: detection of oxidatively modified proteins in substantia nigra. Neurochemistry. 68:(6):1997;2458-2468
26. Vyas S., Javoy-Agid F., Herrero M.T., Strada O., Boissiere F., Hibner U., Agid Y. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J. Neurochem. 69:(1):1997;223-231
27. Winter C., Schenkel J., Zimmermann M., Herdegen T. MAP kinase phosphatase 1 is expressed and enhanced by FK506 in surviving mamillary, but not degenerating nigral neurons following axotomy. Brain. Res. 801:1998;198-205
28. Winter C., Weiss C., Martin-Villalba A., Zimmermann M., Schenkel J. JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy. Mol. Brain Res. 104:2002;194-202
29. Wisdom R. AP-1: one switch for many signals. Exp. Cell Res. 253:1999;180-185
30. Yamada M., Oligino T., Mata M., Goss J.R., Glorioso J.C., Fink D.J. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc. Natl. Acad. Sci. USA. 96:(7):1999;4078-4083
31. Yamamoto K., Ichijo H., Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19:1999;8469-8478
32. Zea Longa E., Weinstein P.R., Carlson S., Cummis R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91
33. Zhong L.T., Sarafian T., Kane D.J., Charles A.C., Mah S.P., Edwards R.H., Bredesen D.E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA. 90:1993;4533-4537